About
Vlad Vitoc is the founder, chairman, chief executive officer, and president of MAIA Biotechnology, a Chicago-based public oncology company developing telomere-targeting cancer therapeutics. MAIA's management page says he has about 20 years of experience across strategic analysis, planning, and medical affairs, and has supported more than 20 compounds across over 25 tumor types. He holds an M.D. from the University of Medicine and Pharmacy "Iuliu Hatieganu" in Cluj-Napoca, Romania, and an M.B.A. from the University of South Carolina.
Areas of interest
biotechoncologyimmuno-oncologytelomere biologycancer therapeuticslung cancer